Onsdag 3 December | 16:39:53 Europe / Stockholm

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-11-28 08:39:00

With its pilot facility now fully operational, Thor Medical has secured a string of strategic supply agreements that propel the company toward full-scale commercial production. This commercial momentum has led to to the investment in AlphaOne, the company's first industrial-scale facility, positioning Thor Medical as a key supplier of alpha-emitters for next-generation precision cancer treatments. BioStock contacted CEO Jasper Kurth to learn more.